Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.enGene, a privately held biotechnology company, has raised $6.4 million in a series A financing, consisting of new investment and conversion of an existing convertible note financing.
Subscribe to our email newsletter
The financing was led by Saad Investments Company and included Masa Life Science Ventures of Washington, District of Columbia and private investors.
Eric Adams, president and CEO of engine, said: “This significant, internationally syndicated financing will provide us with sufficient funds to achieve several near-term, value-driving milestones in the development of the GEMS-Insulin program, which will then lay the foundation for a series B financing in the second half of 2008.”